Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
allinonemovie / Pixabay

Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published

According to a story from pm360online.com, the biopharmaceutical company Insmed Incorporated recently announced that the data from its Phase 3 clinical trial of amikacin liposome inhalation suspension (ALIS). ALIS was…

Continue Reading Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases
Pexels / Pixabay

The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases

Recent medical developments have led to new drugs designed to treat rare genetic disorders. However, the high cost of many of these drugs limits the number of patients who have…

Continue Reading The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases
Close Menu